Predictive factors of mortality in severe community-acquired pneumonia: A model with data on the first 24h of ICU admission

Medicina Intensiva

Volumn 37, Issue 5, 2013, Pages 308-315

  Sirvent, J M ^a   Carmen de la Torre, M ^b   Lorencio, C ^a   Tache A ^a   Ferri, C ^a   Garcia Gil, J ^c   Torres, A ^d  

^a HOSPITAL JOSEP TRUETA   (Spain)

^b HOSPITAL DE MATARÓ   (Spain)

^c UNIVERSITY OF GIRONA   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

Author keywords

ICU; Mortality; Predictive factors; Severe community acquired pneumonia

Indexed keywords

ACUTE KIDNEY FAILURE; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGE; AGED; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; CHRONIC KIDNEY FAILURE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; CURB SEVERITY SCORE; DISEASE SEVERITY; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; OBSERVATIONAL STUDY; PREDICTION; PROGNOSIS; PROSPECTIVE STUDY; SAPS II SEVERITY SCORE; SCORING SYSTEM; SEPTIC SHOCK; STATISTICAL MODEL;

COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MODELS, STATISTICAL; PATIENT ADMISSION; PNEUMONIA, BACTERIAL; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84878656211     PISSN: 02105691     EISSN: 15786749     Source Type: Journal    
DOI: 10.1016/j.medin.2013.03.003     Document Type: Article

References (37)

1. Mandell L.A., Wunderink R.G., Anzueto A., Bartlett J.G., Campbell G.D., Dean N.C., et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007, 44(Suppl. 2):S27-S72.
2. Spindler C., Ortqvist A. Prognostic score systems and community-acquired bacteraemic pneumococcal pneumonia. Eur Respir J 2006, 28:816-823.
3. Leeper K.V., Torres A. Community-acquired pneumonia in the intensive care unit. Clin Chest Med 1995, 16:155-171.
4. Feikin D.R., Schuchat A., Kolczak M., Barrett N.L., Harrison L.H., Lefkowitz L., et al. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am J Public Health 2000, 90:223-229.
5. Fine M.J., Auble T.E., Yealy D.M., Hanusa B.H., Weissfeld L.A., Singer D.E., et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997, 336:243-250.
6. Lim W.S., Baudouin S.V., George R.C., Hill A.T., Jamieson C., Le Jeune I., et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009, 64(Suppl. 3):1-55.
7. Lim W.S., van der Eerden M.M., Laing R., Boersma W.G., Karalus N., Town G.I., et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003, 58:377-382.
8. Liapikou A., Ferrer M., Polverino E., Belasso V., Esperatti M., Piñer R., et al. Severe community-acquired pneumonia: validation of the Infectious Diseases Society of America/American Thoracic Society guidelines to predict an intensive care unit admission. Clin Infect Dis 2009, 48:377-385.
9. Rello J., Rodriguez A., Lisboa T., Gallego M., Lujan M., Wunderink R. PIRO score for community-acquired pneumonia: a new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia. Crit Care Med 2009, 37:456-462.
10. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A., Knaus W.A., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine, 1992. Chest 2009, 136(Suppl.):e28.
11. Dellinger R.P., Levy M.M., Carlet J.M., Bion J., Parker M.M., Jaeschke R., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008, 34:17-60.
12. Brower R.G., Lanken P.N., Macintyre N., Matthay M.A., Morris A., Ancukiewicz M., et al. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004, 351:327-336.
13. Kellum J.A., Bellomo R., Ronco C. Definition and classification of acute kidney injury. Nephron Clin Pract 2008, 109:c182-c187.
14. Le Gall J.R., Lemeshow S., Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993, 270:2957-2963.
15. Sirvent J.M., Vidaur L., Gonzalez S., Castro P., de Batlle J., Castro A., et al. Microscopic examination of intracellular organisms in protected bronchoalveolar mini-lavage fluid for the diagnosis of ventilator-associated pneumonia. Chest 2003, 123:518-523.
16. Meduri G., Chastre J. The standardization of bronchoscopic techniques for ventilator-associated pneumonia. Chest 1992, 102(Suppl. 1):557S-564S.
17. Frei C.R., Restrepo M.I., Mortensen E.M., Burgess D.S. Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia. Am J Med 2006, 119:865-871.
18. Bodí M., Rodríguez A., Solé-Violán J., Gilavert M.C., Garnacho J., Blanquer J., et al. Community-Acquired Pneumonia Intensive Care Units (CAPUCI) Study Investigators. Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America guidelines on survival. Clin Infect Dis 2005, 41:1709-1716.
19. Buising K.L., Thursky K.A., Black J.F., MacGregor L., Street A.C., Kennedy M.P., et al. A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia. Thorax 2006, 61:419-424.
20. Paganin F., Lilienthal F., Bourdin A., Lugagne N., Tixier F., Génin R., et al. Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor. Eur Respir J 2004, 24:779-785.
21. Valencia M., Badia J.R., Cavalcanti M., Ferrer M., Agustí C., Angrill J., et al. Pneumonia severity index class V patients with community-acquired pneumonia: characteristics, outcomes, and value of severity scores. Chest 2007, 132:515-522.
22. Brochard L., Mancebo J., Wysocki M., Lofaso F., Conti G., Rauss A., et al. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med 1995, 333:817-822.
23. Ferrer M., Esquinas A., Leon M., Gonzalez G., Alarcon A., Torres A. Noninvasive ventilation in severe hypoxemic respiratory failure: a randomized clinical trial. Am J Respir Crit Care Med 2003, 168:1438-1444.
24. Non-invasive ventilation in acute respiratory failure. Thorax 2002, 57:192-211. British Thoracic Society Standards of Care Committee.
25. Jolliet P., Abajo B., Pasquina P., Chevrolet J.C. Non-invasive pressure support ventilation in severe community-acquired pneumonia. Intensive Care Med 2001, 27:812-821.
26. Carrillo A., Gonzalez-Diaz G., Ferrer M., Martinez-Quintana M.E., Lopez-Martinez A., Llamas N., et al. Non-invasive ventilation in community-acquired pneumonia and severe acute respiratory failure. Intensive Care Med 2012, 38:458-466.
27. Ruiz M., Ewig S., Marcos M.A., Martinez J.A., Arancibia F., Mensa J., et al. Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. Am J Respir Crit Care Med 1999, 160:397-405.
28. Yandiola P.P., Capelastegui A., Quintana J., Diez R., Gorordo I., Bilbao A., et al. Prospective comparison of severity scores for predicting clinically relevant outcomes for patients hospitalized with community-acquired pneumonia. Chest 2009, 135:1572-1579.
29. Rello J. Demographics, guidelines, and clinical experience in severe community-acquired pneumonia. Crit Care 2008, 12(Suppl. 6):S2.
30. Charles P.G., Wolfe R., Whitby M., Fine M.J., Fuller A.J., Stirling R., et al. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis 2008, 47:375-384.
31. Chen C.Z., Fan P.S., Lin C.C., Lee C.H., Hsiue T.R. Repeated pneumonia severity index measurement after admission increases its predictive value for mortality in severe community-acquired pneumonia. J Formos Med Assoc 2009, 108:219-223.
32. Karmakar G., Wilsher M. Use of the 'CURB 65' score in hospital practice. Intern Med J 2010, 40:828-832.
33. Rodriguez A., Lisboa T., Blot S., Martin-Loeches I., Solé-Violan J., De Mendoza D., et al. Mortality in ICU patients with bacterial community-acquired pneumonia: when antibiotics are not enough. Intensive Care Med 2009, 35:430-438. Community-Acquired Pneumonia Intensive Care Units (CAPUCI) Study Investigators.
34. Sabatier C., Peredo R., Villagrá A., Bacelar N., Mariscal D., Ferrer R., et al. Community-acquired pneumonia: a 7-years descriptive study. Usefulness of the IDSA/ATS 2007 in the assessment of ICU admission. Med Intensiva 2010, 34:237-245.
35. Gilavert Cuevas M.C., Bodí Saera M. Prognostic factors in severe community pneumonia. Med Intensiva 2004, 28:419-424.
36. Woodhead M., Welch C.A., Harrison D.A., Bellingan G., Ayres J.G. Community-acquired pneumonia on the intensive care unit: secondary analysis of 17,869 cases in the ICNARC Case Mix Programme Database. Crit Care 2006, 10(Suppl. 2):S1.
37. Rodriguez A., Alvarez-Rocha L., Sirvent J.M., Zaragoza R., Nieto M., Arenzana A., et al. Recommendations of the Infectious Diseases Work Group (GTEI) of the Spanish Society of Intensive, Critical Care Medicine, Coronary Units (SEMICYUC), the Infections in Critically Ill Patients Study Group (GEIPC) of the Spanish Society of Infectious Diseases, Clinical Microbiology (SEIMC) for the diagnosis, treatment of influenza A/H1N1 in seriously ill adults admitted to the Intensive Care Unit. Med Intensiva 2012, 36:103-137.